BIOMAT Database Logo BIOMAT Database Logo

Calcitonin therapy in osteoporotic syndromes. 1994

L V Avioli
Washington University School of Medicine, St. Louis, Missouri.

Since its introduction in 1961, calcitonin has effectively been used to reverse bone loss observed in paraplegic patients, atrophy of bone, and other disorders. This article focuses on the effect of calcitonin therapy in the treatment of osteoporosis.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015663 Osteoporosis, Postmenopausal Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency. Bone Loss, Perimenopausal,Bone Loss, Postmenopausal,Perimenopausal Bone Loss,Postmenopausal Bone Loss,Postmenopausal Osteoporosis,Osteoporosis, Post-Menopausal,Bone Losses, Perimenopausal,Bone Losses, Postmenopausal,Osteoporoses, Post-Menopausal,Osteoporoses, Postmenopausal,Osteoporosis, Post Menopausal,Perimenopausal Bone Losses,Post-Menopausal Osteoporoses,Post-Menopausal Osteoporosis,Postmenopausal Bone Losses,Postmenopausal Osteoporoses
D016103 Spinal Fractures Broken bones in the vertebral column. Hangman Fracture,Hangman's Fracture,Fracture, Hangman,Fracture, Hangman's,Fracture, Spinal,Fractures, Spinal,Hangmans Fracture,Spinal Fracture
D016723 Bone Remodeling The continuous turnover of BONE MATRIX and mineral that involves first an increase in BONE RESORPTION (osteoclastic activity) and later, reactive BONE FORMATION (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium HOMEOSTASIS. An imbalance in the regulation of bone remodeling's two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS. Bone Turnover,Bone Turnovers,Remodeling, Bone,Turnover, Bone,Turnovers, Bone

Related Publications

L V Avioli
Calcitonin on osteoporotic bone fragility.
October 1990, Calcified tissue international,
L V Avioli
Circulating monomer-like calcitonin in osteoporotic patients.
January 1996, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
L V Avioli
Generalized and focal dystonic syndromes: possible therapy with salmon calcitonin.
January 1985, European neurology,
L V Avioli
Calcitonin in the treatment of osteoporotic bone pain.
July 1992, The Journal of family practice,
L V Avioli
Reduced calcitonin reserve in young hypogonadic osteoporotic men.
June 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
L V Avioli
Managing acute osteoporotic vertebral fractures with calcitonin.
October 1998, Canadian family physician Medecin de famille canadien,
L V Avioli
[Improvement of QOL in osteoporotic patients by calcitonin treatment].
March 2005, Clinical calcium,
L V Avioli
Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women.
February 1986, Calcified tissue international,
L V Avioli
The analgesic role of calcitonin following osteoporotic fracture.
November 2002, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
L V Avioli
[Calcitonin in the treatment of algodystrophic syndromes].
June 1985, La Clinica terapeutica,
Copied contents to your clipboard!